Abzena understand that drug design and development is highly technical and complex. At our Cambridge facility in the UK, we have years of experience in early discovery services ahead of lead optimization and candidate selection for both complex biologics and bioconjugates.

Our development approach is underpinned by world-class analytical and bioassay capabilities that generate high-quality data to make critical decisions earlier, driving good decision-making, and de-risking the path to IND.